Robert Ross Carter - 21 May 2025 Form 4 Insider Report for Oncology Institute, Inc. (TOI)

Reporting relationship: Chief Financial Officer
Issuer ticker: TOI
Reported as of: 21 May 2025
Net transaction value: -$4,283
SEC form: 4
Accepted by SEC: 22 May 2025, 14:12:47 UTC
Prior SEC filing: 02 Apr 2025
Next SEC filing: 19 Nov 2025
Source filing: View source filing
Reporting owner signature: /s/ Mark Hueppelsheuser, Attorney-in-fact for Robert Carter

Key filing fact

Robert Ross Carter filed Form 4 for Oncology Institute, Inc. (TOI) on 22 May 2025.

Key facts

This page summarizes Robert Ross Carter's Form 4 filing for Oncology Institute, Inc. (TOI).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 22 May 2025, 14:12.

Change

Previous filing in this sequence was filed on 02 Apr 2025.
Current net transaction value: -$4,283.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002039341 Primary reporting owner

Carter Robert Ross

Relationship: Chief Financial Officer
Address: C/O THE ONCOLOGY INSTITUTE INC., 18000 STUDEBAKER RD #800, CERRITOS
Signature: /s/ Mark Hueppelsheuser, Attorney-in-fact for Robert Carter
Signature date: 22 May 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TOI transaction

Class A Common Stock

Disposed to Issuer

Transaction value: $4,283
Shares: -1,601
Change %: -0.68%
Price: $2.68
Shares after: 235,174
Date: 21 May 2025
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) pursuant to a sell-to-cover provision included in the RSU Agreement.